MA31800B1 - Dérivés de tétrahydroquinoléine pour traiter des troubles de stress post-traumatique - Google Patents
Dérivés de tétrahydroquinoléine pour traiter des troubles de stress post-traumatiqueInfo
- Publication number
- MA31800B1 MA31800B1 MA32806A MA32806A MA31800B1 MA 31800 B1 MA31800 B1 MA 31800B1 MA 32806 A MA32806 A MA 32806A MA 32806 A MA32806 A MA 32806A MA 31800 B1 MA31800 B1 MA 31800B1
- Authority
- MA
- Morocco
- Prior art keywords
- ptsd
- treatment
- tetrahydroquinoline derivatives
- derivatives
- group
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Abstract
L'invention concerne l'utilisation de dérivés de tétrahydroquinoléine représentés par la formule (i), r1 et r2 représentant chacun indépendamment un groupe alcoxy en c1-c4, r3 représentant un groupe arylalkyle en c1-c4 ou hétéroarylalkyle en c1-c4, et r4 représentant un atome d'hydrogène ou un groupe alkyle en c1-c4, ou de sels pharmaceutiquement acceptables de ces dérivés, pour la préparation d'un médicament destiné à prévenir ou traiter des troubles de stress post-traumatique.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IB2007054130 | 2007-10-10 | ||
| PCT/IB2008/054138 WO2009047723A2 (fr) | 2007-10-10 | 2008-10-09 | Dérivés de tétrahydroquinoléine pour traiter des troubles de stress post-traumatique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA31800B1 true MA31800B1 (fr) | 2010-10-01 |
Family
ID=40467356
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA32806A MA31800B1 (fr) | 2007-10-10 | 2010-04-30 | Dérivés de tétrahydroquinoléine pour traiter des troubles de stress post-traumatique |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US9532985B2 (fr) |
| EP (1) | EP2207550B1 (fr) |
| JP (1) | JP5883222B2 (fr) |
| KR (1) | KR101733247B1 (fr) |
| CN (1) | CN101820878B (fr) |
| AR (1) | AR068768A1 (fr) |
| AU (1) | AU2008309194B2 (fr) |
| BR (1) | BRPI0818617A2 (fr) |
| CA (1) | CA2699504C (fr) |
| CY (1) | CY1114799T1 (fr) |
| DK (1) | DK2207550T3 (fr) |
| EA (1) | EA017443B1 (fr) |
| ES (1) | ES2444418T3 (fr) |
| HK (1) | HK1145440A1 (fr) |
| HR (1) | HRP20140214T1 (fr) |
| IL (1) | IL204838A (fr) |
| MA (1) | MA31800B1 (fr) |
| MX (1) | MX2010003711A (fr) |
| MY (1) | MY153044A (fr) |
| NZ (1) | NZ585086A (fr) |
| PE (1) | PE20091010A1 (fr) |
| PL (1) | PL2207550T3 (fr) |
| PT (1) | PT2207550E (fr) |
| SI (1) | SI2207550T1 (fr) |
| TW (1) | TWI428129B (fr) |
| UA (1) | UA99150C2 (fr) |
| WO (1) | WO2009047723A2 (fr) |
| ZA (1) | ZA201003251B (fr) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008078291A1 (fr) | 2006-12-22 | 2008-07-03 | Actelion Pharmaceuticals Ltd | Dérivés de 5,6,7,8-tétrahydro-imidazo[1,5-a]pyrazine |
| CN102076694A (zh) | 2008-06-25 | 2011-05-25 | 埃科特莱茵药品有限公司 | 5，6，7，8-四氢-咪唑并[1，5-a]吡嗪化合物 |
| EP2402322A1 (fr) | 2010-07-02 | 2012-01-04 | Actelion Pharmaceuticals Ltd. | Dérivé de 1,2,3,4-tétrahydroisoquinoline et son utilisation comme antagoniste du récepteur de l'orexine |
| CA2807000C (fr) | 2010-08-24 | 2018-12-04 | Actelion Pharmaceuticals Ltd | Derives de proline sulfonamide comme antagonistes des recepteurs de l'orexine |
| SI2626350T1 (sl) | 2010-09-22 | 2015-09-30 | Eisai R&D Management Co., Ltd. | Spojina ciklopropana |
| US9242970B2 (en) | 2010-11-10 | 2016-01-26 | Actelion Pharmaceuticals Ltd. | Lactam derivatives useful as orexin receptor antagonists |
| WO2012085857A1 (fr) | 2010-12-22 | 2012-06-28 | Actelion Pharmaceuticals Ltd | 3,8-diaza-bicyclo[4.2.0]oct-3-ylamides |
| ES2541531T3 (es) | 2011-02-18 | 2015-07-21 | Actelion Pharmaceuticals Ltd. | Nuevos derivados de pirazol e imidazol útiles como antagonistas de orexina |
| WO2012114252A1 (fr) | 2011-02-21 | 2012-08-30 | Actelion Pharmaceuticals Ltd | Nouveaux amides d'indole et de pyrrolopyridine |
| WO2013050938A1 (fr) | 2011-10-04 | 2013-04-11 | Actelion Pharmaceuticals Ltd | Dérivés de 3,7-diazabicyclo[3.3.1]nonane et de 9-oxa-3,7- diazabicyclo[3.3.1]nonane |
| TWI565703B (zh) | 2011-11-08 | 2017-01-11 | 艾克泰聯製藥有限公司 | ２-（１，２，３-***-２-基）苯甲醯胺及３-（１，２，３-***-２-基）吡啶醯胺衍生物 |
| EP2855453B1 (fr) | 2012-06-04 | 2016-12-07 | Actelion Pharmaceuticals Ltd. | Dérivés de benzimidazole-proline |
| CN104703980B (zh) | 2012-10-10 | 2017-09-22 | 埃科特莱茵药品有限公司 | 属于[邻双(杂)芳基]‑[2‑(间双(杂)芳基)吡咯烷‑1‑基]甲酮衍生物的食欲素受体拮抗剂 |
| KR20150130413A (ko) | 2013-03-12 | 2015-11-23 | 액테리온 파마슈티칼 리미티드 | 오렉신 수용체 길항제로서의 아제티딘 아미드 유도체 |
| PT3077389T (pt) | 2013-12-03 | 2017-12-15 | Idorsia Pharmaceuticals Ltd | Forma cristalina de (s)-(2-(6-cloro-7-metil-1hbenzo[d]imidazol-2-il)-2-metilpirrolidin-1-il)(5-metoxi-2-(2h-1,2,3-triazol-2-il)fenil)metanona e a sua utilização como como antagonistas do receptor de orexina |
| UA119151C2 (uk) | 2013-12-03 | 2019-05-10 | Ідорсія Фармасьютікалз Лтд | КРИСТАЛІЧНА СОЛЬОВА ФОРМА (S)-(2-(6-ХЛОР-7-МЕТИЛ-1H-БЕНЗО[d]ІМІДАЗОЛ-2-ІЛ)-2-МЕТИЛПІРОЛІДИН-1-ІЛ)(5-МЕТОКСИ-2-(2H-1,2,3-ТРИАЗОЛ-2-ІЛ)ФЕНІЛ)МЕТАНОНУ ЯК АНТАГОНІСТ ОРЕКСИНОВОГО РЕЦЕПТОРА |
| LT3077391T (lt) | 2013-12-04 | 2018-10-25 | Idorsia Pharmaceuticals Ltd | Benzimidazolo prolino darinių panaudojimas |
| WO2016063995A1 (fr) | 2014-10-23 | 2016-04-28 | Eisai R&D Management Co., Ltd. | Compositions et méthodes pour traiter l'insomnie |
| CN115710250A (zh) * | 2017-08-01 | 2023-02-24 | 博健制药有限责任公司 | 一种食欲素受体拮抗剂的晶型及其制备方法和用途 |
| WO2020007964A1 (fr) | 2018-07-05 | 2020-01-09 | Idorsia Pharmaceuticals Ltd | Dérivés de 2-(2-azabicyclo [3.1.0] hexan-1-yl)-1h-benzimidazole |
| WO2020007977A1 (fr) | 2018-07-06 | 2020-01-09 | Idorsia Pharmaceuticals Ltd | Dérivés de 7-trifluorométhyl-[1,4]diazépane |
| WO2020099511A1 (fr) | 2018-11-14 | 2020-05-22 | Idorsia Pharmaceuticals Ltd | Dérivés de benzimidazole-2-méthyl-morpholine |
| TW202400149A (zh) | 2022-05-13 | 2024-01-01 | 瑞士商愛杜西亞製藥有限公司 | 經噻唑并芳基-甲基取代之環狀肼-n-甲醯胺衍生物 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL150986A0 (en) * | 2000-03-14 | 2003-02-12 | Actelion Pharmaceuticals Ltd | 1,2,3,4,- tetrahydroisoquinoline derivatives |
| CN100432056C (zh) * | 2003-03-26 | 2008-11-12 | 埃科特莱茵药品有限公司 | 四氢异喹啉基乙酰胺衍生物作为阿立新受体拮抗剂的应用 |
| AU2005250077B2 (en) * | 2004-03-01 | 2011-06-09 | Idorsia Pharmaceuticals Ltd | Substituted 1,2,3,4-tetrahydroisoquinoline derivatives |
| US7501395B2 (en) | 2005-04-25 | 2009-03-10 | Eisai R & D Management Co., Ltd. | Method of screening for antianxiety drugs |
| CA2644010A1 (fr) * | 2006-03-15 | 2007-09-20 | Actelion Pharmaceuticals Ltd | Derives de tetrahydroisoquinoleine pour renforcer la fonction de la memoire |
| EP2402322A1 (fr) | 2010-07-02 | 2012-01-04 | Actelion Pharmaceuticals Ltd. | Dérivé de 1,2,3,4-tétrahydroisoquinoline et son utilisation comme antagoniste du récepteur de l'orexine |
-
2008
- 2008-10-07 PE PE2008001739A patent/PE20091010A1/es not_active Application Discontinuation
- 2008-10-09 PT PT88079371T patent/PT2207550E/pt unknown
- 2008-10-09 WO PCT/IB2008/054138 patent/WO2009047723A2/fr active Application Filing
- 2008-10-09 PL PL08807937T patent/PL2207550T3/pl unknown
- 2008-10-09 EA EA201000557A patent/EA017443B1/ru not_active IP Right Cessation
- 2008-10-09 MX MX2010003711A patent/MX2010003711A/es active IP Right Grant
- 2008-10-09 NZ NZ585086A patent/NZ585086A/en unknown
- 2008-10-09 EP EP08807937.1A patent/EP2207550B1/fr active Active
- 2008-10-09 CN CN2008801113334A patent/CN101820878B/zh active Active
- 2008-10-09 UA UAA201005122A patent/UA99150C2/ru unknown
- 2008-10-09 MY MYPI2010001561A patent/MY153044A/en unknown
- 2008-10-09 TW TW097139093A patent/TWI428129B/zh active
- 2008-10-09 ES ES08807937.1T patent/ES2444418T3/es active Active
- 2008-10-09 KR KR1020107010186A patent/KR101733247B1/ko active IP Right Grant
- 2008-10-09 CA CA2699504A patent/CA2699504C/fr active Active
- 2008-10-09 JP JP2010528515A patent/JP5883222B2/ja active Active
- 2008-10-09 AU AU2008309194A patent/AU2008309194B2/en not_active Ceased
- 2008-10-09 US US12/681,802 patent/US9532985B2/en active Active
- 2008-10-09 DK DK08807937.1T patent/DK2207550T3/da active
- 2008-10-09 AR ARP080104422A patent/AR068768A1/es unknown
- 2008-10-09 BR BRPI0818617-0A patent/BRPI0818617A2/pt not_active Application Discontinuation
- 2008-10-09 SI SI200831152T patent/SI2207550T1/sl unknown
-
2010
- 2010-04-06 IL IL204838A patent/IL204838A/en active IP Right Grant
- 2010-04-30 MA MA32806A patent/MA31800B1/fr unknown
- 2010-05-07 ZA ZA2010/03251A patent/ZA201003251B/en unknown
- 2010-12-17 HK HK10111852.2A patent/HK1145440A1/xx not_active IP Right Cessation
-
2014
- 2014-02-04 CY CY20141100085T patent/CY1114799T1/el unknown
- 2014-03-10 HR HRP20140214AT patent/HRP20140214T1/hr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA31800B1 (fr) | Dérivés de tétrahydroquinoléine pour traiter des troubles de stress post-traumatique | |
| TNSN07178A1 (fr) | N-sulfonylaminobenzyl-2-phenoxy-acetamides substitues | |
| MA31373B1 (fr) | Composes amino-heterocycliques | |
| MA28747B1 (fr) | Dérivés de pyridine | |
| MA26875A1 (fr) | Composes azapolycycliques a noyau aryle condensé | |
| TNSN04137A1 (fr) | Nouveaux composes heterocycliques, actifs comme inhibiteurs de beta-lactamases | |
| MA31988B1 (fr) | Derives d'aminopyrazole | |
| MA31979B1 (fr) | (cyclopropylphenyl) phenyloxamides, leur procede de production et leur utilisation comme medicament | |
| MA30403B1 (fr) | Derives d'acides cycloalkylamines et leurs compositions pharmaceutiques | |
| MA33636B1 (fr) | Dérivés aminopropioniques substitués comme inhibiteurs de néprilysine | |
| WO2005012269A8 (fr) | Nouveau compose azole | |
| TNSN05073A1 (fr) | Quinazolinones spirocondensees nouvelles et leur utilisation comme inhibiteurs de phosphodiesterase | |
| MA27735A1 (fr) | Heterocycles de n-aryle substitues, procede pour leur preparation et leur utilisation en tant que medicaments | |
| MA31710B1 (fr) | (carboxylalkylenephenyl)phényloxamides, procédés pour la production de ceux-ci et utilisation de ceux-ci en tant que medicament | |
| SE0104334D0 (sv) | Therapeutic agents | |
| HK1077567A1 (en) | Dibenzylamine compound and medicinal use thereof | |
| TN2009000450A1 (fr) | Derives de pyridine | |
| MA31146B1 (fr) | Composes inhibant la phosphoinositide 3 kinase et procedes d'utilisation | |
| MA34450B1 (fr) | Dérivés de l'imidazopyridine, procédé pour leur préparation, et leur utilisation thérapeutique | |
| MA29926B1 (fr) | Derives de pyrazine | |
| WO2002008219A3 (fr) | Nouvelles 2-adamantylethylamines et leur utilisation dans le traitement d'etats generalement associes a des anomalies de la transmission glutamatergique | |
| MA30420B1 (fr) | Derives de terphenyle pour le traitment de la maladie d'alzheimer | |
| DE60130119D1 (de) | Phenylpyridazinderivate und diese enthaltende arzneimittel | |
| MY146599A (en) | New azetidine compounds | |
| MA31674B1 (fr) | Dérivés de 7 -alkynyl-1,8-naphthyridones, leur préparation et leur application en thérapeutique |